Stocks in Action: Fresenius Medical Care, Brenntag, Drägerwerk, Renk, Nordex
Reading Time: 4 minutes
Stock 1.) Fresenius Medical Care - Dialysis specialist benefits from rising patient numbers, Goldman Sachs raises price target to €62 and confirms with Buy (upside potential: 33%) One of the most important buy ratings comes on Monday from Goldman Sachs for Fresenius Medical Care. The dialysis specialist announced further extensive cost-cutting measures during its recent Capital Markets Day. Accordingly, the company aims to save around €1.05 billion by the end of 2027, revising the original savings target for 2025 upwards by €300 million....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
